Health Care Archives - Page 441 of 478

1 minute read

RedHill Shares Gain As European Commission Grants Orphan Drug Status To NTM Infections Candidate

August 17, 10:55 AM

The European Commission has granted Orphan Drug Designation to RedHill Biopharma’s (NASDAQ: RDHL) lead asset RHB-204 for the treatment of nontuberculous mycobacteria (NTM) disease.

RDHL

1 minute read

AbbVie Calls Off Early-Stage Trial For I-Mab’s CD47-Targeted Blood Cancer Candidate

By Vandana Singh

August 17, 10:19 AM

I-Mab (NASDAQ:IMAB) disclosed in an SEC filing that AbbVie Inc (NYSE:ABBV) would discontinue the global Phase 1b study of lemzoparlimab combination therapy with…

ABBV

1 minute read

Intercept Settles Ocaliva Litigation With Reddy’s Lab

By Vandana Singh

August 17, 10:16 AM

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) and its subsidiary Intercept Pharma Europe Limited settled patent litigation with Dr. Reddy’s Laboratories Ltd (NYSE:RDY). The litigation concerns…

ICPT

1 minute read

AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report

By Vandana Singh

August 17, 10:11 AM

AstraZeneca Plc (NASDAQ:AZN) has filed suit against former VP and head of investor relations Chris Sheldon as he prepares…

AZN

1 minute read

Palisade Bio Shares Drop Following Commencement Of Late-Stage Return Of Bowel Study

By Ragothaman Srinivasan

August 17, 9:44 AM

Palisade Bio (NASDAQ: PALI) has dosed first patient in its Phase 3 study evaluating lead asset LB1148 to accelerate the return of bowel function in adult patients undergoing gastrointestinal surgery.

PALI

1 minute read

GSK’s Rare Blood Cancer Candidate Goes Under FDA Review

By Vandana Singh

August 17, 8:44 AM

The FDA has accepted GSK plc’s (NYSE:GSK) marketing application for momelotinib, a potential new medicine with a proposed differentiated mechanism of…

GSK

1 minute read

Israeli Ministry Of Health Approves National Coverage For CytoSorb

By Bill Haddad

August 17, 7:22 AM

PRINCETON, N.J., Aug. 17, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via

CTSO

2 minute read

Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

August 16, 5:54 PM

The U.S. Food and Drug Administration (FDA) has approved Amphastar’s (NASDAQ:AMPH) New Drug Application (ND”) for Epinephrine injection…

AMPH

1 minute read

This Inflammatory Disease Focused Stock Is Well Positioned For $12B Crohn’s Disease Market

By Vandana Singh

August 16, 3:52 PM

Credit Suisse says that Ventyx Biosciences Inc’s (NASDAQ:VTYX) topline Phase 1 MAD data for its allosteric TYK2 inhibitor, VTX958 establishes clear differentiation from…

VTYX

1 minute read

These Depression Players Are Top Picks For $400B Mental Healthcare Market, Says Analyst

By Vandana Singh

August 16, 3:40 PM

HC Wainwright expects COMPASS Pathways Plc (NASDAQ: CMPS) and Cybin Inc (NYSE: CYBN) to be leaders in the emerging $400 billion mental healthcare market.

CMPS